Resilience

We were excited to connect with our partners at Labcorp, a global laboratory network with solutions spanning the entire cell and gene therapy development continuum, during Meeting on the Mesa. We take pride in our strategic collaboration, which delivers a comprehensive customer service offering for the pre-clinical, clinical development, and commercial manufacturing of cell and gene therapies (CGT). This partnership enhances our ability to provide streamlined planning, increased flexibility, and shared expertise across the drug development continuum. If you’d like to discuss expedited timelines, cost efficiencies, and risk mitigation throughout the pre-clinical, clinical, and commercial processes, schedule a time to talk to our team: https://hubs.ly/Q02SY4p10 #CGMesa24

On October 15 at 11am ET, join us for a roundtable discussion on "Key Steps in the Vaccine Scale-Up Journey," featuring experts in the field: Dr. Doris Snow, Isabel Scholz, PhD, MBA Scholz, and Justin L. Batte, PhD with Tarek Abdel-Gawad moderating. You’ll hear strategies to overcome challenges related to bioreactors, tech transfers, and regulatory compliance. 📅 Date: October 15 🕚 Time: 11am ET Interactive polls and Q&A sessions will provide valuable insights tailored to professionals in vaccine development and biomanufacturing. Don’t miss out—RSVP today: https://hubs.ly/Q02SVjWV0

It's the final day of CPhI Worldwide! Catch up with the Resilience team at Stand #7C98 to learn how we're revolutionizing how medicines are made, funded and scaled. Stop in for a cappuccino and conversation to help power through day 3. We'll see you soon! #CDMO #doseofcaffeine

A big thank you to L7 Informatics’ Marcia Blackmoore, the panelists, and everyone who attended the panel yesterday featuring Resilience’s Eytan Abraham, Ph.D., on “Maximizing Flexibility and Connectivity: Unified Platform Solutions for Manufacturing, Scheduling, and Supply Chain Management.” We’re thrilled to connect with so many industry leaders at the Meeting on the Mesa and explore how Resilience can support your goals in the cell and gene therapy space. If you’d like to continue the conversation, feel free to schedule a meeting with our team here: https://hubs.ly/Q02SNy4S0  #CGMesa24

The Resilience team is geared up for day 2 of CPhI Worldwide! If we missed you yesterday, be sure to stop by for great conversation and a cappuccino with our team at Stand #7C98. We look forward to discussing how we can support your next development or manufacturing program. #CPHIWW #CDMO

The countdown is over - CPhI Worldwide begins today! Meet Christina Bevilacqua and the rest of the Resilience team at stand 7C98 in Milan, Italy. We look forward to making new connections and meeting with colleagues throughout the week. Be sure to stop by to grab a cappuccino and some great conversation to learn how Resilience can support your next development or manufacturing program. We'll see you soon! #CPhIWW #partners #CDMO

We are looking forward to hearing Eytan Abraham Ph.D., speak at the 2024 Cell Therapies & Immunotherapy Conference. Join us on October 30 at 11:00 AM at the Manchester Grand Hyatt San Diego for his presentation titled “Enabling 5-day turnaround of Autologous Cell Therapies through a Short Process coupled with an NGS QC Solution.” Eytan will discuss how our innovative approach integrates a proven 3-day CAR-T manufacturing process with a novel NGS-based 48-hour QC release solution. This combination not only reduces turnaround times but also drives down costs, ultimately helping to deliver life-saving therapies to critically ill patients more efficiently. Can’t make it to the conference? Check out our event list for additional opportunities to link up: https://hubs.ly/Q02S3j650

We’re pleased to share that Resilience has secured nearly $17.5 million to enhance domestic manufacturing of critical pharmaceutical ingredients. This funding, awarded to our subsidiary, Resilience Government Services, Inc., from the HHS Administration for Strategic Preparedness and Response (ASPR)'s Center for Industrial Base Management and Supply Chain (IBMSC) supports our mission to improve access to essential medicines. In partnership with the BioMaP-Consortium | Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP) and Aralez Bio, we’ll leverage advanced biocatalysis technology to streamline production processes for active pharmaceutical ingredients (APIs) in the United States. ➡️Read press release: https://hubs.ly/Q02S3t8J0

Are you ready to take your cell and gene therapy projects to the next level? The Resilience team is gearing up for Meeting on the Mesa in Phoenix from October 7-9, and we’re excited to meet with you! Connect in person with Eytan Abraham, Uzair Beg, Wesley Tidball, MBA, and Mazen Karaman by scheduling a meeting with us: https://hubs.ly/Q02RzpPP0. We look forward to seeing you in Phoenix! #CGMesa24

Today, we connected with the patients who inspire our work every day. 💖 Their stories of strength and hope are a reminder of the heart behind our therapies and the impact we strive to make. Moments like these fuel our commitment to accelerate the way medicines are made and remind us that every step forward counts. Thank you to everyone who made today so special! #PatientDay #Resilience #RTP